Congress to Consider Major Medicaid Changes in September, Grassroots Advocacy Campaign Needed During Congressional Recess Action Alert at the NAMI web site - " This week the House and Senate began a month long summer recess, during which members of Congress will be in their states and districts across the country. One of the major issues Congress will confront upon their return to work in September is how to reduce future Medicaid expenditures by $10 billion over the next five years. These reductions to Medicaid will be considered as a part of a massive budget 'reconciliation' measure that Congress is supposed to complete sometime in the fall. This "reconciliation" legislation will include a number of programmatic changes to Medicaid that could have an enormous impact on beneficiaries (both children and adults) living with mental illness. NAMI is very concerned that these reductions to Medicaid do not adversely impact on access to treatment support services for Medicaid beneficiaries living with mental illness."  
comment []    

FDA Responds to Criticism With New Caution August 6 New York Times article - "Stung by a series of drug safety scandals, the Food and Drug Administration has in recent months issued a blizzard of drug-safety warnings and approval times for new drugs are slower. The agency is issuing twice the number of public advisories about drug risks as it did a year ago and adding five times as many black box warnings - its most serious alert - to drug labels. And drugs approved in the first half of this year took almost twice as long to get that approval as drugs approved in the same period last year. This new conservatism, a response to fierce recent criticism from Congress that the F.D.A. has failed to protect the public against drug dangers, has upset some doctors and drug makers..." [Viewing New York Times resources requires registration, which is free].  
comment []    

Data Behind Antidepressant Advisory Don't Give Clear-Cut Answers  Psychiatric News story - "The FDA's most recent public health advisory regarding antidepressants appears to have been based on seemingly contradictory studies published earlier this year. The FDA's June 30 public health advisory concerning antidepressants was prompted, the advisory said, by 'several recent scientific publications' that suggested 'the possibility of an increased risk for suicidal behavior in adults who are being treated with antidepressant medications.' FDA spokesperson Christine Parker told Psychiatric News that the advisory was prompted by 'two papers of particular interest.' Both appeared in the February 19 BMJ..." See also abstracts of the BMJ studies.  
comment []    

FDA Alert Covers Cymbalta  Psychiatric News story - "In conjunction with its release of the public health advisory regarding increased risk of suicide in adults taking antidepressants, the FDA issued a separate FDA Alert involving duloxetine (Cymbalta) and suicidality in pediatric and adult patients. The alert largely echoes the language of the advisory, noting that the FDA is 'highlighting that adults being treated with any type of antidepressant medication, particularly those being treated for depression, should be watched closely for worsening of depression and for increased suicidal thinking or behavior.' "  
comment []    

Texas Health Official Explains Effort To End Mental Illness Stigma  Psychiatric News story - "Deep in the heart of Texas, NAMI members learn about several new initiatives on destigmatization and prevention of mental illness for those living in the state. Government officials in Texas, the state that hosted the 2005 annual conference of the National Alliance for the Mentally Ill (NAMI), are setting an example for other states by taking steps to eliminate the stigma that surrounds mental illness. Part of their focus will be on implementing strategies for preventing mental illness in those at risk for these disorders."  
comment []    

Identifying Patients' Treatment Goals Helps Overcome Noncompliance  Psychiatric News story - "Though many patients with anosognosia refuse to take psychotropic medications because they don't believe they are ill, some may take them to quell loved ones' concerns. To stem what some call an 'epidemic; of medication noncompliance for patients with serious mental illness, psychiatrists must tie treatment directly to patients' goals. This was a key message delivered to mental health consumers, family members, psychiatrists, and mental health professionals who attended the 2005 annual conference of the National Alliance for the Mentally Ill in Austin, Texas, in June."  
comment []    

Latino Behavioral Health Institute to Present Eleventh Annual Conference Prime Zone press release - "Latino Behavioral Health Institute (LBHI), one of the nation's largest non-profit organizations dedicated to eliminating discrimination against Latinos in need of behavioral health services and health care, will present its eleventh annual international conference, Tuesday, Wednesday and Thursday, Sept. 20 -- 22, at the Universal Hilton Hotel in Universal City, Calif. Themed, 'Transformation: Towards Access and Quality in Latino Behavioral Health,' the event will address contemporary issues of policy, training, research, clinical practice and education related to Latino mental health, substance abuse, health and human services. Approximately 1,000 behavioral health professionals from the United States, Puerto Rico, Mexico and South American countries are expected to attend."  
comment []